BioSpace News Archive

Checkpoint Surgical, Inc. announced the publication of the first peer-reviewed study comparing the use of its Checkpoint Nerve Stimulator/Locator to Medtronic’s Nerve Integrity Monitor for neural monitoring during thyroid and parathyroid surgeries in the April 2019 edition of The Laryngoscope.

Biocom, the association representing the California life science industry, today announced that it has added Matt Abernethy, chief financial officer of Neurocrine Biosciences, and Sabrina Martucci Johnson, president and chief executive officer of Daré Biosciences, to its board of directors.

One Week Ahead of Hurricane Season, Many Americans Remain Unprepared and Reliant on State and Local Resources

TridentUSA Health Services today announced the appointment of Jane Pike-Benton, MS, RN to the position of Vice President, Home Health Strategy. Ms. Pike-Benton joined TridentUSA Health Services in February 2019 to lead its TridentCare at Home team.

With cell and gene therapies revolutionizing cancer treatment, curing major diseases with a single administration, and commanding blockbuster prices, biologics manufacturers are clamoring to move the “next big drug” into the marketplace.

CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research — has unveiled a six-episode discussion series featuring Laura O’Brien, who shares her journey through stage 3 non-small cell lung cancer (NSCLC) and immunotherapy with Dr. Jyoti D. Patel.

HQP will provide services to three southern California counties with a targeted outreach to four ethnic population groups and three targeted languages

Amgen (NASDAQ: AMGN) will host a webcast investor meeting at ASCO 2019 on Monday, June 3 at 6:30 p.m.

Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for cell therapies, to develop and commercialize fit-for-purpose instrumentation and reagent systems aimed at improving productivity and scalability of cell and gene therapy manufacturing.

Audentes Therapeutics, Inc. (Nasdaq: BOLD), today announced that it has appointed Edward R. Conner, M.D. as Senior Vice President and Chief Medical Officer and promoted Fulvio Mavilio, Ph.D. to Senior Vice President of Translational Science.